Роль иммунотропных лекарственных препаратов природного и синтетического происхождения в профилактике острых респираторных инфекций

Abstract

Respiratory tract infections (influenza, acute respiratory infections (ARIs), community-acquired pneumonia, etc.) pose a serious threat to organized groups (including military personnel, cadets, students of military universities, and schools). The most common complication of ARI is community-acquired pneumonia, severe forms of which may result in an unfavorable outcome. The use of some drugs, such as Carmolis ensures a 2.0–3.8 times reduction in the incidence of ARIs in organized groups and a 2.3–3.0 times reduction in the incidence of community-acquired pneumonia. Carmolis has a pronounced non-specific protective effect and increases resistance to respiratory tract infections by promoting nonspecific resistance of the organism. This prevents significant economic damage and reduces the number of complications and poor outcomes. Keywords: organized groups, biological and social emergencies, respiratory tract infections, community-acquired pneumonia, acute respiratory infections, coronavirus infection, Carmolis, non-specific resistance, non-specific prevention of acute respiratory infections, epidemiological effectiveness